Skip to content
★ Sign in to follow
RG

Robert Glanzman

Directeur Médical
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€9,173

Latest filing published 18 May 2022 for Clene Inc., €9,173.

Filing timeline

BuySale
Robert Glanzman

Insider track record

Disclosed buys
0
Disclosed sells
1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Robert Glanzman: trading record in brief

Robert Glanzman is a declared insider of Clene Inc. (senior executive), with filings sourced from SEC (Form 4). Between 30 June 2021 and 16 May 2022, the trades on record add up to 2 filings.

Sales make up the whole of the open-market record (1 sale, €9,173). The rest of the record consists of 1 share grant. Since January 2022: no purchases and 1 sale on the market.

The newest entry dates from 18 May 2022: an open-market sale of €9,173, in Clene Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert Glanzman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    Chief Medical OfficerExecutivesClene Inc.
    9,576 USD31SEC
    4,717 shares@ US$2.03100.0% of flowCommon StockSEC:0001562180-22-004174:0
  • ◆
    Chief Medical OfficerExecutivesClene Inc.
    0SEC
    15,281 shares0Common StockSEC:0001562180-21-004607:0

2 of 2 declarations